AI is fundamentally different than previous health technologies. Over the next few years, AI will be able to diagnose, treat, and manage chronic diseases—with little to no direct human intervention.
This presents a once-in-a-generation opportunity to redesign healthcare delivery and fundamentally change the underlying economics of care. If we get it right, we can expand access to high-quality care while lowering costs.
But that future won’t happen under today’s reimbursement models.
Existing payment approaches either reward more activity—driving up spending with increased adoption—or reward outcomes, which may be insufficient to incentivize high-value clinical AI adoption at scale.
To explore this challenge, Peterson Health Technology Institute (PHTI) convened senior leaders from across healthcare, technology, and policy to discuss how payment models need to evolve as AI moves from assisting clinicians to autonomously delivering aspects of care.
The following takeaways emerged:
1️⃣ Applying today’s payment options to clinical AI will both inflate costs under models that reward activity and hamper adoption under models that incentivize outcomes.
2️⃣ Payment models for AI should lower the cost of care, be outcome-based, and adapt as the evidence base grows and clinicians’ roles evolve.
3️⃣ Autonomous clinical AI – unlike assistive AI – requires new payment models, not incremental modifications to existing ones.
The decisions we make about how to pay for clinical AI now will shape not only its adoption, but whether the technology ultimately delivers on the promise of improving outcomes, expanding access to care, and lowering healthcare costs.
Read the full workshop summary: https://lnkd.in/gDFYF9Ts